Guangzhou Concord Cancer Center

The Proton Center at Guangzhou Concord Cancer Center houses South China's first Varian ProBeam proton radiotherapy system, marking the region's entry into the era of proton therapy for cancer treatment. The center is equipped with four 360° rotating gantry treatment rooms, utilizing advanced pencil beam scanning technology to deliver Intensity-Modulated Proton Therapy (IMPT). This technology achieves highly conformal target coverage and dose distribution, significantly reducing radiation exposure to healthy tissues and organs. The system integrates Cone-Beam Computed Tomography (CBCT) for precise patient positioning, enabling Image-guided Proton Therapy (IGPT) to further enhance accuracy and safety. The Proton Center strictly adheres to MD Anderson Cancer Center radiotherapy guidelines and standard procedures, integrating NCCN Clinical Practice Guidelines and domestic CSCO guidelines to provide scientifically grounded treatment plans. Through its telemedicine collaboration network with Mayo Clinic, patients can access comprehensive diagnostic and treatment opinions from internationally renowned experts. The core team members have extensive experience working or training at top-tier international medical institutions and have contributed to the development of domestic guidelines and medical textbooks.

MD Anderson Cancer Center: Ranked No.1 in the "Best Cancer Hospitals in the United States" by U.S. News & World Report for successive years. GCCC has collaborated with MD Anderson in clinical capability and quality system development, staff training, and hospital operations management. Dr. Charles M. Balch, Professor of Surgical Oncology at MD Anderson, serves as Chief Medical Consultant. Mayo Clinic: Ranked No.1 in the "Best Hospitals in the United States" by U.S. News & World Report multiple times. As a strategic partner, Mayo Clinic collaborates with GCCC across quality, diagnosis and treatment models, medical education, innovation, and patient experience to build an international cancer hospital with Chinese characteristics. From November 2019 to May 2020, Dr. Yuan Taize, Chief Physician at GCCC, completed specialized training in proton radiotherapy at Mayo Clinic.

GCCC is equipped with cutting-edge international medical technology, enabling patients to access premier diagnostic and treatment services without going abroad: • Varian ProBeam Proton Therapy System — First in South China, 4 rotating gantry rooms, IMPT + IGPT capable • Da Vinci Surgical Robot — Precision minimally invasive surgery • PET-MRI — Next-generation molecular imaging • PET-CT — High-precision tumor metabolic imaging • TrueBeam Linear Accelerators — 4 photon treatment rooms, the world's most advanced new-generation LINAC • Digital, integrated, modular Class-100 laminar flow operating rooms

The following proton therapy indications are compiled from MD Anderson Proton Therapy Center (partial list): Head & Neck Tumors: Nasopharyngeal neoplasm, oropharyngeal neoplasm, orbital tumor, skull base tumor, nasal and paranasal sinuses tumor, relapsed or newly diagnosed malignant tumor within previous radiation field Chest Tumors: Non-small cell lung cancer, esophageal carcinoma, thymoma, mesothelioma, bilateral N2 lesions after lung cancer surgery, relapsed cancer or prior chest radiation Gastrointestinal Tumors: Hepatocellular carcinoma, intrahepatic cholangiocarcinoma (ICC), solitary liver metastasis in colorectal cancer Urogenital Neoplasms: Early-stage or locally advanced prostate cancer with curative treatment indications, solitary pelvic lymph node metastasis CNS Tumors: Meningioma and sellar tumor, low-grade gliomas, primary CNS tumor requiring craniospinal irradiation Breast & Gynecological: Patients with Accelerated Partial Breast Irradiation (APBI) indications Pediatric Tumors: Astrocytoma, craniopharyngioma, ependymoma, Ewing's sarcoma, glioma, medulloblastoma, retinoblastoma, rhabdomyosarcoma, osteosarcoma, teratoma Sarcoma & Lymphoma: Mediastinal lymphoma, paraspinal lymphoma, patients requiring total brain and spinal cord irradiation